skip to Main Content
Hacarus Opens Offices In Bayer’s CoLaborator Kobe

October, 1st, 2019 – Kyoto, Japan – Hacarus Inc, the leading provider of lightweight and explainable AI, today announced the opening of its new office in Bayer’s CoLaborator Kobe space – located in the Kobe Medical Industrial City on Port Island.

“As we continue leading the development of explainable AI solutions for the medical field, I am excited to announce the opening of our new offices with our partners at Bayer. This new location will allow us to reach further into cutting edge research institutions located in the Kobe cluster Said Kenshin Fujiwara”, CEO and Founder, Hacarus.

CoLaborator is Bayer’s global collaboration space for supporting life science start-ups, with locations across Berlin, San Francisco, Sacramento, Moscow and Kobe – Hacarus is the first AI company to setup at the Japanese branch.

CoLaborator Kobe located in Japan’s largest biomedical cluster, provides easy access to research institutions and facilities including the Advanced Medical Center, RIKEN Multi-Cell System Formation Research Center (CDB) and highly specialized hospitals such as the Kobe Minimally Invasive Cancer Medical Center. Please visit the CoLaborator Kobe website to learn more https://www.colaborator.jp/

Hacarus is opening its offices within the CoLaborator Kobe location to accelerate joint developments with research institutions and medical institutions, and further collaboration with pharmaceutical companies. In addition to diagnosis and treatment support, Hacarus will promote the use of its AI for unmet medical needs in various fields including drug discovery and regenerative medicine.

About Bayer Yakuhin
Bayer Yakuhin is headquartered in Osaka and is a healthcare company consisting of ethical drugs, consumer health and veterinary drugs. The ethical drug division focuses on the cardiovascular, oncology / blood, women’s healthcare, ophthalmology, and diagnostic imaging fields. In the Consumer Health segment, Bayer Yakushin is focused on the antipyretic analgesic “Bayer Aspirin” as well as allergic diseases and dermatology. The Animal Health Division contributes to the health care of companion animals and livestock animals with a focus on providing veterinary drugs. The company aims to be an advanced pharmaceutical company that meets the unfulfilled wishes of Japanese patients through technological innovation and innovative products. For more information, please visit www.byl.bayer.co.jp/

Email: pr@hacarus.com

About Hacarus
Hacarus Inc. founded 2014, in Kyoto, Japan is the leading provider of explainable lightweight AI Tools, backed by Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical and Manufacturing fields to enable humans to make better, faster and more reliable decisions, based on AI driven insights. Hacarus proprietary AI engine is built using Sparse Modeling, an AI method that understands data like a human would – by its unique key features and is far more resource, time and energy efficient compared to deep learning. To learn more visit https://hacarus.com